Wednesday, June 10, 2026

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,492

Quick answer

1,492 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 7303754

    MVA expressing modified HIV envelope, gag, and pol genes

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7288369

    Replication competent hepatitis C virus and methods of use

    The Board of Regents of the University of Texas System · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7285383

    Method for selective inactivation of viral replication

    Rigel Pharmaceuticals, Inc. · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7282205

    Anti-hepatitis A virus antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7279306

    Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof

    The Regents of the University of Colorado · Granted Tue Oct 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7276227

    Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7273851

    Tri-peptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Sep 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7268122

    Use of oversulfated polysaccharides as inhibitors of HIV

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7262027

    Polypeptide and DNA immunization against Coccidioides spp. infections

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7259167

    Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof

    The United States of America as represented by the Secretary of the Army · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7253275

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7247307

    Vaccines against Escherichia coli O157 infection

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7244617

    Diminishing viral gene expression by promoter replacement

    The Board of Regents of the University of Texas System · Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7238800

    Peptides and DNA encoding the peptides useful for immunizations against Coccidioides spp. infections

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jul 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7235234

    Bacterial delivery system

    The United States of America as represented by the Secretary of the Army · Granted Tue Jun 26 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7235644

    Vaccine against Gram-negative bacterial infections

    The United States of America as represented by the Secretary of the Army · Granted Tue Jun 26 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7232566

    Methods for treating HIV infected subjects

    The United States as represented by the Secretary of the Navy · Granted Tue Jun 19 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7227011

    Nucleic acid vaccines for prevention of flavivirus infection

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7223388

    Modified reoviral therapy

    The Board of Regents of the University of Texas System · Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7223787

    Prenylation inhibitors reduce host cell permissiveness to viral replication

    The Board of Regents of the University of Texas System · Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7223585

    Viral purification methods

    ONCOLYTICS BIOTECH INC. · Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7220421

    Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of Moraxella bovis infections

    The Regents of the University of California · Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7217541

    Method of making CS6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections

    The United States of America as represented by the Secretary of the Army · Granted Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7201911

    Cloned genomes of infectious hepatitis C viruses and uses thereof

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7201902

    Production of recombinant protein pap 31 for the diagnosis and prevention of Bartonella bacilliformis infection

    United States of America as represented by the Secretary of the Air Force · Granted Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7192593

    Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7183268

    2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7183095

    Cell culture system for synthesis of infectious hepatitis C virus

    The Regents of the University of California · Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7176208

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7173007

    Therapy for microbial infections

    The United States of America as represented by the Department of Veteran Affairs · Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7157473

    Pyridyl substituted heterocycles useful for treating or preventing HCV infection

    Rigel Pharmaceuticals, Inc. · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7157495

    Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7153880

    Substituted diphenyl heterocycles useful for treating HCV infection

    Rigel Pharmaceuticals, Inc. · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7151087

    CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

    The United States of America as represented by the Department of Health and Human Resources · Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7148323

    Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7144875

    Methods of treating fungal infections using lupeol

    Regents of the University of Minnesota · Granted Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7135324

    Viral recombinases, related articles, and methods of use thereof

    UNIVERSITY OF CONNECTICUT · Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7132454

    HEXIM1 as a suppressor of HIV replication and cardiac hypertrophy

    The Regents of the University of California · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7132271

    Methods for enhancing the production of viral vaccines in cell culture

    The Regents of the University of California · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7132102

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7129342

    Infectious cDNA clone of GB virus B and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7125845

    Aza-peptide macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7115590

    Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents

    University College Cardiff Consultants Limited · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7115262

    Chimeric protein for prevention and treatment of HIV infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7105171

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7105156

    Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells

    The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7101541

    Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7094598

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Infectious disease patents are indexed?

1,492 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.